RBR-9wgwnj
Recruiting
未知
The influence of dopamine-related genetic polymorphisms on susceptibility and behavior of Migraine
Hospital de Clinicas da Universidade Federal do Paraná.0 sitesMarch 11, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Migraine with aura [classical migraine]
- Sponsor
- Hospital de Clinicas da Universidade Federal do Paraná.
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Will be included individuals who meet the diagnostic criteria for migraine without aura, migraine with aura and / or chronic migraine associated or not with abuse of analgesics; are between 18 and 65 years of age at the time of inclusion; accept to participate in the study on a voluntary basis. The control group will include people who do not suffer from headache and for that, they should answer negatively to the question: Have you ever suffered from frequent headaches and without an obvious cause?. Patients with complaints other than headache will be invited, employees of recruiting institutions, escorts of patients with no familiarity with the study group, volunteers recruited from disclosure by verbal approach or physical media and electronic.
Exclusion Criteria
- •Will be excluded from the study individuals who do not complete all applied scales; present other types of headache concomitantly, such as trigeminal neuralgia and secondary headaches; withdraw the informed consent form.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Dopamine action on metabolism depending on genetic heterogeneity – a randomized, placebo-controlled double blind studyAdipositas ist eine weit verbreitete und in ihrer Prävalenz zunehmende Erkrankung, die mit schwerwiegenden Folgeerkrankungen einhergeht. Von häufigen genetischen Polymorphismen haben Varianten im FTO Lokus die höchste Effektgröße auf das Körpergewicht. Preliminäre, bisher unveröffentlichte Ergebnisse Zeigen, dass eine Verstärkung des DA-signalings mit dem DA-agonisten Bromocriptin in Abhängigkeit vom FTO Genotyp entweder eine Gewichtsreduktion induziert oder einen gewichtsneutralen Effekt hat.MedDRA version: 20.0Level: LLTClassification code 10051361Term: AdipositasSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: LLTClassification code 10029885Term: Obesity, unspecifiedSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Body processes [G] - Metabolic Phenomena [G03]EUCTR2017-003387-12-DEniversity Hospital Tuebingen145
Not yet recruiting
Not Applicable
The impact of dopamine on functional and structural connectivitywetenschappelijk onderzoek met gezonde vrijwilligershealthyNL-OMON42846niversiteit Leiden160
Completed
Phase 2
Genetic Effects on Dopamine Response to an OpiatePolymorphism-GeneticPainAddictionNCT01878006National Institute on Alcohol Abuse and Alcoholism (NIAAA)15
Not yet recruiting
Not Applicable
The effects of increased levels of dopamine on the activation in the dopaminergic system.Disorders related to disturbed dopaminergic functioning.NL-OMON28941Maastircht University20
Unknown
Phase 1
Effect of Gene Variants on Dopamine Receptor Natriuretic ResponsesHypertensionNCT00592150University of Virginia44